Clinical trials
Bacterial Infections clinical trials
Below are recruiting bacterial infections clinical trials, each written for real people, not researchers. We’re tracking 93 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06377592Recruiting
AI for Gram stain test accuracy
This trial is testing an AI tool that analyzes Gram stain test results. It is for patients who have had a Gram stain test ordered, which is a common lab test to identify bacteria. The study aims to see how well the AI works compared to standard methods.
Suita, OsakaAges Any age - NCT06427317Recruiting
Antibiotic effectiveness study in infection patients
This study looks at how well beta-lactam antibiotics (a common type of antibiotic) work in people being treated for infections at Imperial College NHS Trust. The information may help doctors make better dosing decisions.
LondonAges 18 years+ - NCT07739004Recruiting
Fever in Children: Predictors of Serious Illness
This study looks at children with fever to find early signs that might predict serious illness, helping doctors make better triage decisions in the emergency room.
Kayseri, TalasAges birth–18 years - NCT07670624Recruiting
Biomarker test for bacterial infection in newborns
This trial tests a new biomarker (T6A) to detect bacterial infections in newborn babies. It aims to help doctors diagnose infections faster and more accurately.
SalzburgAges Any age - NCT07629986Recruiting
How antibiotics work in cystic fibrosis patients on ETI therapy
This study measures how antibiotics are processed by the body in people with cystic fibrosis who are taking a combination drug called elexacaftor/tezacaftor/ivacaftor (ETI). Understanding this helps doctors prescribe the right antibiotic doses for patients on this newer treatment.
RoscoffAges 12 years+ - NCT07612163Recruiting
Antibiotic levels and effectiveness in patients with liver cirrhosis
This study measures how antibiotic drugs called beta-lactams work in people with cirrhosis (liver damage). Researchers will check antibiotic blood levels to see if standard doses are right for cirrhotic patients or need adjustment.
Nanjing, JiangsuAges 18 years+ - NCT06166381Recruiting
Antibiotics in ACL reconstruction: vein vs. vein plus soaked graft
This trial compares two methods for preventing infection during ACL reconstruction surgery. One group gets antibiotics through a vein, and the other group gets antibiotics through the vein plus a special antibiotic-soaked graft placed in the knee.
DuhokAges 20–45 - NCT07478484RecruitingPhase 4
Different ways to take antibiotics for resistant infections
This trial tests two different schedules of a combination of antibiotics (ceftazidime-avibactam plus aztreonam) for people with serious infections caused by bacteria that are hard to treat. It aims to find the best way to give these medicines.
Nanjin, JiangsuAges 18–100 - NCT06814899Recruiting
Fosfomycin for bacterial infections in hospitalized adults
This study looks at how well the antibiotic fosfomycin works for bacterial infections in patients who received it in the hospital. It may help doctors understand the best ways to use this medicine.
Lecco, LeccoAges 18 years+ - NCT07285785RecruitingPhase 4
Rifaximin for children with acute diarrhea
This study tests whether a medicine called rifaximin, taken along with oral rehydration solution, helps children aged 6 to 11 recover faster from acute (short-lasting) diarrhea that is likely caused by a bacterial infection. The study compares rifaximin plus oral rehydration versus oral rehydration alone.
Lynwood, CaliforniaAges 6–12 - NCT05914779Recruiting
Early antibiotics after out-of-hospital cardiac arrest
This study looks at whether starting antibiotics soon after an out-of-hospital cardiac arrest helps patients who are unlikely to have an infection. Antibiotics may prevent or treat infection-related complications, but only if certain infection and health conditions are met.
Doha, Baladiyat ad DawhahAges 18 years+ - NCT07113951Enrolling by invitation
AI-ROSE for diagnosing severe pneumonia
This trial uses an AI tool called AI-ROSE to analyze lung fluid from a bronchoscopy. It aims to help doctors quickly diagnose severe pneumonia and guide treatment.
Nanjing, JiangsuAges 18 years+ - NCT07062445Recruiting
Tracking treatment and outcomes for children with meningitis
This study follows children with meningitis to see how well treatments work and what happens in the long run. If your child has a fever and signs of meningitis (like a stiff neck, headache, or rash), they may be able to join.
São Paulo, São PauloAges Up to 17 years - NCT07051525Recruiting
Early vs. late stopping of antibiotics for fever in blood cancer treatment
This trial compares stopping antibiotics early (after fever resolves) versus continuing them as usual in adults with blood cancers who develop fever during treatment. It aims to find the best timing to reduce unnecessary antibiotic use.
Melbourne, VictoriaAges 18 years+ - NCT07044726RecruitingPhase 4
Betadine vs sterile water for catheter cleaning
This trial compares using Betadine (an iodine-based antiseptic) versus sterile water to clean the area before a catheter is placed in the doctor's office. The goal is to see which method better prevents infections during the procedure.
Louisville, KentuckyAges 18 years+ - NCT05922124RecruitingPhase 4
Testing two antibiotics against resistant lung and bloodstream infections
This trial studies whether cefiderocol plus ampicillin-sulbactam works better than colistin (sometimes with meropenem) for serious infections caused by carbapenem-resistant Acinetobacter baumannii (a hard-to-treat germ). It may help by finding a more effective antibiotic plan for people with these severe hospital-acquired infections.
HaifaAges 16 years+ - NCT06618989Recruiting
Predicting serious bacterial infection in febrile infants
This trial is testing a new blood test to help doctors tell which babies under three months with fever are at risk for a serious bacterial infection. If successful, it could help avoid unnecessary antibiotics and hospital stays.
Paris, FranceAges 1 week–3 months - NCT05350813Recruiting
Using procalcitonin to stop antibiotics earlier safely
This study tests whether a blood test called procalcitonin can help doctors stop intravenous antibiotics earlier in young hospitalized children when an infection seems likely. The goal is to reduce unnecessary antibiotic exposure without missing serious infections.
AmiensAges 3 days–17 years - NCT04633603Enrolling by invitation
Study of attitudes toward fever and fever care changes
This study looks at how people think about fever and how fever care works in the healthcare system. You may be asked to record details of fever episodes at home or in outpatient care to help researchers understand real-world fever management.
PécsAges Up to 100 years - NCT04263792RecruitingPhase 1
Scan trial to track a new tracer in suspected bacterial infections
This Phase 1 study uses a special scan tracer ([18F]F-TMP) to see how it moves in the body and how fast it changes in people with suspected or known bacterial infections. It’s mainly testing the scan’s behavior and safety, which may help future infection-targeting imaging.
Philadelphia, PennsylvaniaAges 18 years+ - NCT06655272RecruitingPhase 4
OM 85 to prevent lung infections in older nursing home residents
This study tests a medication called OM 85 that may help prevent respiratory infections (like pneumonia) in older adults living in nursing homes. If you are 75 or older and have had infections recently, this trial could be a way to stay healthier.
Roma, RMAges 75 years+ - NCT07619924Enrolling by invitationEarly Phase 1
Phage Cocktail for Hard-to-Treat Skin Infections
This study tests a new treatment called a phage cocktail (viruses that kill bacteria) for skin infections caused by bacteria that don't respond well to regular antibiotics. The treatment is applied directly to the wound to see if it's safe and effective.
Xi'an, ShaanxiAges 18–75 - NCT06250985RecruitingPhase 3
New treatment for infected heart device: quick re-implant
This trial tests if a new, faster approach to replacing an infected pacemaker or defibrillator is safe. If you have a heart device infection and meet recovery milestones, you might be able to get a new device sooner than usual.
Frederiksberg, CopenhagenAges 18–110 - NCT05284318Recruiting
Antibiotic plans and outcomes after two-stage joint revision
This study looks at how antibiotic treatment (especially the course length and approach) relates to infection control and results after a two-step surgery for joint infections. If you’ve had a spacer placed, finished at least 6 weeks of antibiotics, and then had the second surgery, the research team may want to follow your outcomes over time.
Fuzhou, FujianAges 18 years+
Hear when a new Bacterial Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for bacterial infections?
- Yes. Clin2 currently lists 93 recruiting bacterial infections studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a bacterial infections trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a bacterial infections trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.